Nordson Corp Stock Price, News & Analysis

Nordson (Nasdaq: NDSN) has announced its upcoming Investor Day, scheduled for October 3, 2024, in New York City. The event will begin at 1:00 p.m. ET and will be accessible via webcast on the company's investor relations website. During the presentation, Nordson's senior management team will provide an overview of the business, discuss progress on the Ascend Strategy, and outline future growth plans.

Key speakers at the event will include Sundaram Nagarajan (President and CEO), Daniel Hopgood (CFO), and executives from various segments of the company. The presentation will highlight Nordson's competitive advantages, product portfolio, and capital deployment focus.

Nordson , headquartered in Westlake, Ohio, is a precision technology company serving diverse end markets including consumer non-durable, medical, electronics, and industrial sectors. Founded in 1954, the company operates in over 35 countries worldwide.

Nordson (Nasdaq: NDSN) has announced the pricing of its $600 million offering of 4.500% notes due 2029. The offering is expected to close on September 9, 2024, subject to customary conditions. The company plans to use the net proceeds to:

• Repay borrowings under its $500 million 364-Day Term Loan
• Pay transaction-related fees and expenses
• Fund general corporate purposes

The Term Loan was used to finance Nordson's acquisition of Atrion on August 21, 2024. Morgan Stanley & Co. , BNP Paribas Securities Corp., and Wells Fargo Securities, are acting as joint book-running managers for the offering, which is being made under an effective shelf registration statement filed with the SEC.

Nordson Electronics Solutions will showcase advanced fluid dispensing technologies for semiconductor packaging at SEMICON Taiwan 2024, booth L0516. The company will feature the ASYMTEK Forte® fluid dispensing system, designed for high-productivity and accuracy in various semiconductor packaging applications. Nordson will also present developments for high-throughput panel-level packaging (PLP) and wafer-level packaging (WLP), addressing challenges like warpage during fluid dispensing.

The exhibition will highlight different configurations of the ASYMTEK Vantage® fluid dispensing system for WLP and PLP, demonstrating precise dispense results with high throughput. Experts will be available to discuss how Nordson can support the manufacturing of reliable semiconductor products. SEMICON Taiwan is scheduled for September 4-6, 2024, at TaiNEX, Taipei Taiwan.

Nordson (NDSN) reported Q3 fiscal 2024 results with sales of $662 million, up 2% year-over-year. Earnings per diluted share were $2.04, while adjusted EPS reached $2.41, exceeding guidance by $0.08. The company increased its full fiscal year 2024 revenue guidance to reflect the Atrion acquisition but maintained its adjusted EPS guidance. Q3 sales included a 4% favorable acquisition impact, offset by a 1% organic sales decrease and 1% unfavorable currency translation. EBITDA was $208 million, or 31% of sales. Nordson updated its full-year revenue guidance to $2,665 million - $2,705 million and adjusted EPS to $9.45 - $9.65, unchanged at the midpoint but now including the slightly dilutive Atrion impact in Q4.

Nordson (Nasdaq: NDSN) has completed the acquisition of Atrion , a leader in proprietary medical infusion fluid delivery and niche cardiovascular solutions. This strategic move expands Nordson's medical portfolio into new markets and therapies, supported by long-term secular growth trends. The acquisition, initially announced on May 28, 2024, aligns with Nordson's innovative precision technology focus and scalable growth framework.

Nordson will provide further details about the acquisition during its third quarter fiscal year 2024 webcast scheduled for Thursday, August 22, 2024, at 8:30 AM ET. The company, founded in 1954 and headquartered in Westlake, Ohio, leverages a direct sales model and applications expertise to serve global customers across consumer non-durable, medical, electronics, and industrial end markets.

Nordson (NDSN) has announced a 15% increase in its quarterly cash dividend, raising it to $0.78 per common share from $0.68. This marks the company's 61st consecutive year of annual dividend increases, placing it among an elite group of companies with the longest-running record of consecutive dividend increases. The dividend is payable on September 10, 2024, to shareholders of record as of August 27, 2024.

Nordson's CFO, Daniel Hopgood, highlighted the company's focus on customer satisfaction, innovation, and differentiation, combined with its Ascend strategy, as key factors in generating consistent cash flows and enabling shareholder value return. Nordson is an innovative precision technology company serving diverse end markets, including consumer non-durable, medical, electronics, and industrial sectors.

Nordson (Nasdaq: NDSN) has announced the release date for its third quarter fiscal year 2024 earnings. The company will publish its financial results on August 21, 2024, after the market closes. A quarterly webcast is scheduled for August 22, 2024, at 8:30 AM ET.

Investors can access the webcast through a provided link and a replay will be available on Nordson's investor website. Nordson, headquartered in Westlake, Ohio, is described as an innovative precision technology company with a scalable growth framework and division-led organization. The company serves global customers across various industries, including consumer non-durable, medical, electronics, and industrial end markets.

Nordson Electronics Solutions has consolidated its European operations into a new state-of-the-art facility in Valkenswaard, The Netherlands. This move integrates multiple sites from Deurne, Maastricht, and Hagenbach, Germany, into a central location to meet rising European customer demand. The new facility features a demonstration lab showcasing the latest equipment from ASYMTEK, MARCH, and SELECT product lines, offering solutions for conformal coating, fluid dispensing, plasma treatment, and selective soldering in electronics manufacturing.

The modern building incorporates environmental efficiency features such as solar panels and energy-conserving underfloor heating, aligning with Nordson 's sustainability commitment. Located in the Eindhoven area, the new site minimizes disruption to customers, partners, and suppliers while supporting customers backed by the European Chips Act to boost regional resilience.

Nordson (Nasdaq: NDSN) announced its agreement to acquire Atrion (Nasdaq: ATRI), a leader in medical infusion and cardiovascular technologies, for $460.00 per share in cash. This acquisition values Atrion at approximately $800 million and expands Nordson’s medical portfolio into new markets and therapies. Atrion generated about $169 million in revenue in 2023 and operates three FDA registered manufacturing facilities in the U.S.

The acquisition will be funded through cash on hand and newly issued financial debt and is expected to close before Nordson’s fiscal year-end in 2024, pending regulatory and stockholder approvals. The transaction is expected to generate significant synergies within the first two years of ownership.

The acquisition aligns with Nordson's strategy to leverage long-term growth drivers in the medical sector, including an aging population, increased healthcare spending, and the adoption of minimally invasive surgical techniques.